BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10683753)

  • 1. [Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Gouzoulis-Mayfrank E; Hermle L; Kovar KA; Sass H
    Fortschr Neurol Psychiatr; 1999 Dec; 67(12):574-6. PubMed ID: 10683753
    [No Abstract]   [Full Text] [Related]  

  • 2. [Psychiatric disorders and consumption of ecstasy drug (MDMA): review of published case reports].
    Bango J; Fadón P; Mata F; Rubio G; Santo-Domingo J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998; 26(4):260-3. PubMed ID: 9807860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
    Gouzoulis-Mayfrank E; Daumann J
    Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Thomasius R; Schmolke M; Kraus D
    Fortschr Neurol Psychiatr; 1997 Feb; 65(2):49-61. PubMed ID: 9157047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Parrott A
    Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
    [No Abstract]   [Full Text] [Related]  

  • 6. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Karlsen SN; Spigset O; Slørdal L
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):15-24. PubMed ID: 18047478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
    Cohen RS
    Biol Psychiatry; 1996 May; 39(9):819-20. PubMed ID: 8731525
    [No Abstract]   [Full Text] [Related]  

  • 8. [MDMA--"ecstasy"].
    Keup W
    Med Monatsschr Pharm; 1996 Jan; 19(1):2-5. PubMed ID: 8583979
    [No Abstract]   [Full Text] [Related]  

  • 9. Methodological problems with ecstasy and the SCL-90.
    Cole JC; Sumnall HR; Wagstaff GF
    Psychopharmacology (Berl); 2002 Jul; 162(2):215-7; discussion 218-22. PubMed ID: 12110999
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma amino acids in ecstasy users.
    Stuerenburg HJ; Petersen K; Buhmann C; Rosenkranz M; Baeumer T; Thomasius R
    Neuro Endocrinol Lett; 2003 Oct; 24(5):348-9. PubMed ID: 14647011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is ecstasy a drug of dependence?
    Degenhardt L; Bruno R; Topp L
    Drug Alcohol Depend; 2010 Feb; 107(1):1-10. PubMed ID: 19836170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Toxicity of ecstasy].
    Mas M; Farré M; Roset PN; Camí J
    Med Clin (Barc); 1998 Oct; 111(13):516-7. PubMed ID: 9859071
    [No Abstract]   [Full Text] [Related]  

  • 13. [MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects].
    Prada C; Alvarez FJ
    Med Clin (Barc); 1996 Oct; 107(14):549-55. PubMed ID: 8999216
    [No Abstract]   [Full Text] [Related]  

  • 14. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E; Fischermann T; Rezk M; Thimm B; Hensen G; Daumann J
    Drug Alcohol Depend; 2005 Jun; 78(3):317-23. PubMed ID: 15893163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ecstasy: idiosyncrasy, overdosage or collateral effects].
    Avila de Tomás JF
    Med Clin (Barc); 1998 Oct; 111(13):517-8. PubMed ID: 9859072
    [No Abstract]   [Full Text] [Related]  

  • 16. Ecstasy (MDMA) and oral health.
    Brand HS; Dun SN; Nieuw Amerongen AV
    Br Dent J; 2008 Jan; 204(2):77-81. PubMed ID: 18268544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR; Kokkalis J
    Hum Psychopharmacol; 2007 Aug; 22(6):381-8. PubMed ID: 17621368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is the anxiety about Ecstasy justified?].
    Möller-Nehring E; Luderer HJ
    Fortschr Med; 1997 Mar; 115(7):28, 31-2, 34. PubMed ID: 9173018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The new drugs: ecstasy, GHB. Update for practitioners].
    Feldman N; Croquette-Krokar M
    Rev Med Suisse Romande; 2001 Dec; 121(12):885-8. PubMed ID: 11803792
    [No Abstract]   [Full Text] [Related]  

  • 20. Criminal involvement among young male ecstasy users.
    Hendrickson JC; Gerstein DR
    Subst Use Misuse; 2005; 40(9-10):1557-75. PubMed ID: 16048833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.